Popular weight-loss medications including Ozempic and Wegovy contain a drug that seems to decrease cravings for food and ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...

A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...

WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...

WeightWatchers (WW) announced Tuesday that it is now offering off-brand weight loss drugs for one of the cheapest prices in ...

Key Takeaways Shares of WW International, better known as WeightWatchers, soared Tuesday after it said it is offering copycat ...

Many people suffering from severe mental illnesses are significantly overweight. New weight loss medications may help extend ...

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...

WW International (NASDAQ:WW), more commonly known as WeightWatchers, will now offer compounded semaglutide to its ...

Compounded semaglutide is semaglutide with an altered formula to create an unbranded alternative to Wegovy and Ozempic.

Semaglutide vs liraglutide treatment demonstrated superior weight loss at 1 year and 10% weight loss achievement among patients with obesity.